Fate Therapeutics, Inc. (FATE)

1.50 +0.04 (+2.74%) USD  |  NASDAQ  |  Feb 23, 13:40
More

Fate Therapeutics Average Basic Shares Outstanding (Quarterly)

Average Basic Shares Outstanding (Quarterly) Chart

View Average Basic Shares Outstanding (Quarterly) for FATE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Basic Shares Outstanding (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Basic Shares Outstanding (Quarterly) Range, Past 5 Years

View Average Basic Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Basic Shares Outstanding (Quarterly) Benchmarks

View Average Basic Shares Outstanding (Quarterly) Benchmarks
Start Trial
MannKind Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Ardelyx, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade